As part of its ongoing investment in advanced manufacturing technology, G. Samaras has strengthened its production capabilities with the acquisition of the Doosan Lynx 2100LSYB mill-turn center. This investment reflects the company’s broader commitment to reinforcing its vertically integrated production model and further enhancing the speed, consistency, and precision with which critical medical gas components are manufactured. At a time when much of the international market continues to move toward outsourcing and production outside the European Union, G. Samaras remains focused on strengthening internal production and preserving direct control over quality, technical execution, and delivery performance. This strategic direction is particularly important in the field of medical gas systems, where component reliability is directly linked to the safety and long-term performance of healthcare infrastructure. By investing in in-house machining capabilities, the company improves coordination between engineering, production, and project execution, while also reducing dependency on external suppliers and minimizing the risks often associated with fragmented supply chains. In this way, vertical integration is not presented merely as a manufacturing preference, but as a deliberate operational strategy that supports faster response times, better production planning, and a more consistent end result for hospitals and healthcare facilities that require dependable and highly specialized solutions.
High-Precision Machining for Critical Medical Gas Components
The manufacture of precision parts for medical gas distribution networks, such as medical gas receptions and components for pressure control assemblies, requires extremely tight tolerances, stable production conditions, and absolute geometric accuracy. In these applications, even the smallest deviation may affect assembly precision, sealing performance, and the long-term operational reliability of the final installation. With its multi-axis kinematics (X, Z, Y, C, B), sub-spindle architecture, and live tooling capabilities, the Doosan Lynx 2100LSYB enables complete machining of complex components in a single phase, reducing handling time and minimizing production variability. Its configuration supports demanding operations such as eccentric drilling, precision milling, and the accurate shaping of sophisticated component features, all within a controlled and highly repeatable process. This integrated machining approach improves repeatability, supports the production of complex geometries, and strengthens the overall stability of the manufacturing workflow for components used in highly sensitive healthcare environments. At the same time, the ability to complete multiple machining stages within one setup helps reduce unnecessary interventions, simplifies production flow, and improves consistency from one batch to the next. As a result, G. Samaras is able to maintain a higher level of manufacturing control and deliver components that meet the strict technical expectations of modern medical gas infrastructure.
Digital Process Control and In-House Manufacturing Efficiency
At the same time, the combination of Mastercam (CAM) programming and Siemens 828D real-time machine control allows G. Samaras to optimize cutting strategies, reduce cycle times, and ensure consistently high part quality without compromising dimensional accuracy. Through Mastercam, machining sequences are digitally designed to achieve efficient material removal, controlled tool engagement, and better repeatability across every production cycle. At machine level, the Siemens 828D system provides stable real-time control of kinematics and supports safe execution under demanding operating conditions, helping maintain precision throughout the process. Together, these technologies create a manufacturing environment where speed and accuracy are developed in parallel, not as competing priorities. More importantly, this investment supports a clear production philosophy: for critical medical infrastructure, quality, responsiveness, and manufacturing consistency must remain under direct control. By continuing to expand its in-house production base rather than following the prevailing trend of outsourced or non-EU manufacturing, G. Samaras improves lead times, reinforces quality assurance, and delivers greater long-term value to hospitals and healthcare projects that depend on reliable medical gas systems. Ultimately, this approach strengthens the company’s position as a trusted manufacturing partner, capable of combining advanced technical capability with the operational discipline required in critical healthcare applications.